GlucoLight Unveils Ergonomic Improvements and Performance Enhancements ...

Quotes

1. “ As SENTRIS-100 continues to be developed and perfected from a technology standpoint, it also becomes imperative for us to improve its design and functionality ”

   By Ray Krauss

2. “ These design and function improvements to SENTRIS-100 effectively productize the monitor as we approach the next round of clinical studies in 2008. We'll also look to build on these advances as we develop our proprietary technology for a future consumer product. ”

   By Ray Krauss

Entities Mentioned

• GlucoLight
• Ray Krauss
• Glucolight Sentris-100

1. PR Inside - Using Optical Coherence Tomography (OCT) based technology, GlucoLight has identified specific physiological targets within the dermis that closely correlate to changes in blood glucose levels. GlucoLight's SENTRIS-100(TM) monitor samples these ... (Read Full Article)

   Bookmark or Share this article

   
   

   Related Articles

   • [Video Profile] Ray Krause, CEO of GlucoLight
   • also mentions GlucoLight
   • GlucoLight Awarded Patent for Tissue Oximetry Measurement Technology
   • also published in Free Services for PR

   • GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing
   • also mentions Glucolight Sentris-100
   • Innolume Secures EUR 8.6 Million New Funding to Ramp up Production and Enhance Market Penetration of Quantum Dot Lasers
   • also published in Free Services for PR

Login to comment.